Prophage landscapes in clinical MRSA: safety profiling and discovery of Lys81, a broad-spectrum bacteriolytic enzyme
A theoretical foundation for the clinical translation of MRSA prophages is established, positioning Lys81 as a novel candidate for treating drug-resistant bacterial infections.